ClinicalTrials.Veeva

Menu

Significance of Immunohistochemical Expression of Survivin in Renal Cell Carcinoma

S

Sohag University

Status

Completed

Conditions

Renal Cell Carcinoma

Treatments

Diagnostic Test: sectioning and staining of renal neoplasms after nephrectomy operation

Study type

Observational

Funder types

Other

Identifiers

NCT04873180
Soh-Med-21-04-28

Details and patient eligibility

About

detection of Survivin expression in renal cell carcinoma and correlate this expression to tumor grade and stage.

Full description

renal cell carcinoma is the third most prevalent malignant tumor of the genitourinary system. deregulation of apoptosis is involved in carcinogenesis by abnormally prolonged cell survival, facilitating accumulations of multiple mutations and augment resistance to immune-surveillance. Survivin is a member of inhibitor of Apoptosis Protein family (IAPs). it play a role in cell cycle regulation by inhibiting apiptosis. Survivin is over-expressed in many human neoplasms.

Enrollment

40 patients

Sex

All

Ages

30 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients suffer from renal cell carcinomas

Exclusion criteria

  • patients received pre-operative chemotherapy or radiotherapy. patients with insufficient clinical data.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems